OR52H1
gene geneOn this page
Summary
OR52H1 (olfactory receptor family 52 subfamily H member 1, HGNC:15218) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 52H1 (Q8NGJ2). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390067 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 50 total
- MANE Select transcript:
NM_001005289
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15218 |
| Approved symbol | OR52H1 |
| Name | olfactory receptor family 52 subfamily H member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000181616 |
| Ensembl biotype | protein_coding |
| Entrez | 390067 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000322653, ENST00000641796
RefSeq mRNA: 1 — MANE Select: NM_001005289
NM_001005289
CCDS: CCDS31386
Canonical transcript exons
ENST00000322653 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001263972 | 5544561 | 5545535 |
| ENSE00003813820 | 5548452 | 5548540 |
Expression profiles
Bgee: expression breadth tissue_specific, 5 present calls, max score 50.70.
Top tissues by expression
111 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 50.70 | gold quality |
| sural nerve | UBERON:0015488 | 49.50 | silver quality |
| bone marrow cell | CL:0002092 | 43.40 | gold quality |
| apex of heart | UBERON:0002098 | 41.92 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 40.09 | silver quality |
| stromal cell of endometrium | CL:0002255 | 39.98 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 39.13 | gold quality |
| tonsil | UBERON:0002372 | 38.24 | gold quality |
| bone marrow | UBERON:0002371 | 37.94 | gold quality |
| granulocyte | CL:0000094 | 37.25 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle tissue | UBERON:0002385 | 35.29 | gold quality |
| liver | UBERON:0002107 | 34.29 | gold quality |
| leukocyte | CL:0000738 | 33.51 | silver quality |
| monocyte | CL:0000576 | 33.46 | silver quality |
| corpus callosum | UBERON:0002336 | 32.37 | gold quality |
| urinary bladder | UBERON:0001255 | 32.10 | gold quality |
| blood | UBERON:0000178 | 30.12 | gold quality |
| cortex of kidney | UBERON:0001225 | 29.65 | gold quality |
| myometrium | UBERON:0001296 | 29.60 | gold quality |
| gall bladder | UBERON:0002110 | 29.54 | silver quality |
| body of uterus | UBERON:0009853 | 29.26 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.23 | gold quality |
| adrenal tissue | UBERON:0018303 | 29.14 | gold quality |
| endometrium | UBERON:0001295 | 28.62 | silver quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| right coronary artery | UBERON:0001625 | 27.59 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.44 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or52h1 | ENSMUSG00000042909 |
| rattus_norvegicus | Or52h1 | ENSRNOG00000017138 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 52H1 — Q8NGJ2 (reviewed: Q8NGJ2)
Alternative names: Olfactory receptor OR11-45
All UniProt accessions (2): A0A126GWQ6, Q8NGJ2
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005289* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (26 total): topological domain 8, transmembrane region 7, sequence variant 7, glycosylation site 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGJ2-F1 | 86.84 | 0.57 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 99–181
Glycosylation sites (2): 5, 269
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 20 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZWANG_DOWN_BY_2ND_EGF_PULSE, REACTOME_OLFACTORY_SIGNALING_PATHWAY, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS
GO Biological Process (5): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), nervous system process (GO:0050877), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| system process | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
246 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR52H1 | UBQLNL | Q8IYU4 | 544 |
| OR52H1 | TAS2R13 | Q9NYV9 | 506 |
| OR52H1 | TAS2R5 | Q9NYW4 | 467 |
| OR52H1 | VN1R4 | Q7Z5H5 | 447 |
| OR52H1 | RALGPS2 | Q86X27 | 447 |
| OR52H1 | TAAR2 | Q9P1P5 | 437 |
| OR52H1 | TAAR5 | O14804 | 432 |
| OR52H1 | TAS2R50 | P59544 | 431 |
| OR52H1 | CNGA4 | Q8IV77 | 424 |
| OR52H1 | VN1R2 | Q8NFZ6 | 419 |
| OR52H1 | VN1R1 | Q9GZP7 | 417 |
| OR52H1 | ZNF514 | Q96K75 | 400 |
| OR52H1 | TAAR9 | Q96RI9 | 390 |
| OR52H1 | TAAR8 | Q969N4 | 379 |
| OR52H1 | TAAR6 | Q96RI8 | 374 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
480 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5544598:T:C | donor_gain | 0.9600 |
| 11:5545854:CCA:C | acceptor_gain | 0.8900 |
| 11:5545610:T:TA | acceptor_gain | 0.8700 |
| 11:5545855:CA:C | acceptor_gain | 0.8400 |
| 11:5545856:A:C | acceptor_gain | 0.8300 |
| 11:5545109:T:TG | acceptor_gain | 0.7600 |
| 11:5544591:A:T | donor_gain | 0.7300 |
| 11:5545303:A:T | acceptor_gain | 0.7200 |
| 11:5548529:C:CT | acceptor_gain | 0.7100 |
| 11:5548530:A:T | acceptor_gain | 0.7100 |
| 11:5545302:CAGCA:C | acceptor_gain | 0.6300 |
| 11:5544846:G:C | acceptor_gain | 0.6200 |
| 11:5545305:C:CT | acceptor_gain | 0.6200 |
| 11:5544840:G:C | acceptor_gain | 0.6100 |
| 11:5545306:A:AC | acceptor_gain | 0.5800 |
| 11:5545534:CC:C | acceptor_gain | 0.5800 |
| 11:5545535:CC:C | acceptor_gain | 0.5800 |
| 11:5544588:TATA:T | donor_gain | 0.5700 |
| 11:5544590:TA:T | donor_gain | 0.5700 |
| 11:5544713:G:T | acceptor_gain | 0.5700 |
| 11:5545306:A:C | acceptor_gain | 0.5700 |
| 11:5544845:C:CT | acceptor_gain | 0.5600 |
| 11:5545212:T:TA | donor_gain | 0.5500 |
| 11:5544908:A:AC | donor_gain | 0.5400 |
| 11:5544909:C:CC | donor_gain | 0.5400 |
| 11:5545452:C:A | donor_gain | 0.5400 |
| 11:5545855:C:T | acceptor_gain | 0.5400 |
| 11:5547872:CCTG:C | donor_gain | 0.5400 |
| 11:5548471:CAAA:C | donor_gain | 0.5400 |
| 11:5544712:CGA:C | acceptor_gain | 0.5300 |
AlphaMissense
2086 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5544996:G:C | F176L | 0.838 |
| 11:5544996:G:T | F176L | 0.838 |
| 11:5544998:A:G | F176L | 0.838 |
| 11:5545464:G:C | F20L | 0.802 |
| 11:5545464:G:T | F20L | 0.802 |
| 11:5545466:A:G | F20L | 0.802 |
| 11:5545194:G:C | F110L | 0.758 |
| 11:5545194:G:T | F110L | 0.758 |
| 11:5545196:A:G | F110L | 0.758 |
| 11:5544747:A:C | F259L | 0.745 |
| 11:5544747:A:T | F259L | 0.745 |
| 11:5544749:A:G | F259L | 0.745 |
| 11:5545320:G:C | F68L | 0.725 |
| 11:5545320:G:T | F68L | 0.725 |
| 11:5545322:A:G | F68L | 0.725 |
| 11:5544708:A:C | F272L | 0.686 |
| 11:5544708:A:T | F272L | 0.686 |
| 11:5544710:A:G | F272L | 0.686 |
| 11:5545218:G:C | F102L | 0.672 |
| 11:5545218:G:T | F102L | 0.672 |
| 11:5545220:A:G | F102L | 0.672 |
| 11:5545407:G:C | F39L | 0.671 |
| 11:5545407:G:T | F39L | 0.671 |
| 11:5545409:A:G | F39L | 0.671 |
| 11:5545176:A:C | F116L | 0.627 |
| 11:5545176:A:T | F116L | 0.627 |
| 11:5545178:A:G | F116L | 0.627 |
| 11:5545140:A:C | F128L | 0.617 |
| 11:5545140:A:T | F128L | 0.617 |
| 11:5545142:A:G | F128L | 0.617 |
dbSNP variants (sampled 300 via entrez): RS1000177241 (11:5549174 A>G), RS1000374325 (11:5547937 G>A), RS1000418927 (11:5549639 C>A), RS1000945554 (11:5548991 T>C), RS1001296197 (11:5548506 T>C,G), RS1002292005 (11:5550146 C>G,T), RS1002322931 (11:5544399 G>A,T), RS1002529773 (11:5544688 G>A), RS1002738507 (11:5547354 T>C,G), RS1003734633 (11:5545585 C>A,T), RS1003756772 (11:5545918 T>C), RS1004399250 (11:5545638 G>A,C,T), RS1004825123 (11:5548893 G>A,T), RS1005199217 (11:5548539 C>A,G,T), RS1005649639 (11:5544413 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008058_108 | Estimated glomerular filtration rate | 4.000000e-18 |
| GCST008059_42 | Estimated glomerular filtration rate | 6.000000e-14 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Sodium Selenite | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.